Metabolon

Heading to ?

We'd love to meet you there.

As researchers increasingly use objective biomarkers to understand dietary exposure and how nutrition influences health, metabolomics provides a powerful way to characterize biochemical responses to diet and uncover why individuals respond differently.

Visit the Metabolon team at Booth #406 to discuss how metabolomics can support your nutrition research.

See you in Washington!

Welcome back to our Women in STEM: Leading the Way in Multiomics series, where we're highlighting the women helping advance multiomics through leadership in metabolomics, bioinformatics, translational science, laboratory operations, quality systems, and scientific strategy.

Today, we feature Dr. Micaiah Ward, Field Metabolomics Scientist at Metabolon.

As Micaiah explains, metabolomics is the missing layer that helps connect genomic, transcriptomic, and proteomic data to biological function. By capturing biology as it unfolds, metabolomics enables researchers to move beyond individual datasets and build a more complete understanding of complex biological systems.

Read Micaiah's full interview here: https://bit.ly/4pCowaX

As the closest molecular proxy to physiology, metabolomics provides the functional context needed to connect genotype, environment, microbiome, and phenotype.

Yet its chemical complexity and the challenge of generating reproducible data have limited its routine inclusion in multiomics studies.

In our latest blog, Brenan Durainayagam explores why metabolomics is essential for unlocking the full potential of multiomics and how the Metabolon Verus™ Metabolomics Profiling Kit was designed to make metabolomics easier to adopt through broad biological coverage, automated data processing, harmonized workflows, and seamless integration with our Integrated Bioinformatics Platform (IBP).

Read the blog to learn how we're helping make metabolomics a routine part of multiomics research.

🔗 https://bit.ly/4vLsnEb

Welcome back to our Women in STEM: Leading the Way in Multiomics series, where we're highlighting the women helping advance multiomics through leadership in metabolomics, bioinformatics, translational science, laboratory operations, quality systems, and scientific strategy.

Today, we feature Leane Woody, Director of Laboratory Operations at Metabolon.

As Leane explains, operational excellence is the foundation that enables metabolomics to scale without compromising quality. By building reproducibility, consistency, and performance into every step of the workflow, Metabolon delivers the reliable data that powers stronger science, meaningful multiomic integration, and confident discovery.

Read Leane's full interview here: https://bit.ly/4pmtXdU

Microbiome research is entering a new era of functional discovery.

Today, we're excited to announce the expansion of Metabolon's Microbiome Panel, now enabling researchers to screen for more than 800 microbiome-associated metabolites.

While metagenomic sequencing reveals microbial community composition and functional potential, metabolomics captures the small molecules microbes produce, transform, or influence — providing functional insights that help connect microbial activity to immune response, disease biology, nutrition, treatment response, and overall health.

With our enhanced Microbiome Panel, researchers can:

🔎 Gain a more comprehensive view of microbiome function with 800+ curated microbiome-associated metabolites

🔬 Explore deeper connections between nutrition, host-microbiome interactions, and disease biology through expanded metabolite coverage

🧬 Integrate metabolomics with metagenomics to uncover biological mechanisms, identify biomarkers, and generate richer multiomic insights

Learn more about the enhanced Microbiome Panel: https://bit.ly/4aTbKPa

How early can we detect the biological changes associated with Alzheimer's disease?

In this new Nature Aging study, researchers used Metabolon's Global Discovery Panel identified metabolic signatures linked to cognition and brain health, offering new insights into Alzheimer's disease risk before clinical symptoms emerge.

Read the highlights below, and access the full publication here:

https://doi.org/10.1038/s43587-026-01149-4

Artificial intelligence is transforming drug development, but most AI platforms rely on genomic, proteomic, and literature-derived datasets that describe biological potential, not biological reality.

Join our upcoming webinar to learn how metabolomics provides the biochemical evidence layer that AI-driven programs are missing. As the downstream readout of gene expression, protein activity, and environmental interaction, metabolomics captures biological state with a directness no other omics layer can match, helping translate computational predictions into biologically grounded development decisions.

In this session, you'll learn:

▸ Why most AI drug discovery platforms are trained on incomplete biology, and how adding metabolomics as a functional data stream sharpens predictions toward phenotype, drug efficacy, and safety

▸ How metabolomics can confirm mechanism of action by resolving uncertain compound mechanisms and identifying true biochemical targets

▸ How pretreatment metabolomic profiling can detect early toxicity signals and stratify patient risk to support more informed go/no-go decisions

▸ How Metabolon's metabolomics platform, with its extensive coverage, reproducibility, and interpretation services, enables these applications across AI-driven drug development

Join Christine Nnyamah and David Pacheco to learn why metabolomics belongs in every AI-powered drug development program.

📅 Tuesday, July 14
🕑 3 pm EDT | 9 pm CEST

Register here: https://bit.ly/4vj3SOi

Welcome back to our Women in STEM: Leading the Way in Multiomics series, where we're highlighting the women helping advance multiomics through leadership in metabolomics, bioinformatics, translational science, laboratory operations, quality systems, and scientific strategy.

Today, we feature Dr. Pamela Nakhle, Senior Director of Quality Assurance and Regulatory Affairs at Metabolon.

As Pamela explains, the value of multiomic research depends on confidence in the data. By embedding quality and regulatory science throughout the research process (and fostering collaboration across R&D, Laboratory Operations, Bioinformatics, Regulatory & Quality, and Translational Science) we can ensure discoveries are not only innovative, but also credible, reproducible, and ready for real-world applications.

Read Pamela's full interview here: https://bit.ly/3QDpve3